<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02951169</url>
  </required_header>
  <id_info>
    <org_study_id>XH-16-034</org_study_id>
    <nct_id>NCT02951169</nct_id>
  </id_info>
  <brief_title>Exploration of Standard Surgical Indication in Gallbladder Benign Disease</brief_title>
  <official_title>Multicenter Cohort Study: To Explore the Standard Surgical Indication in Gallbladder Benign Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Xinhua Hospital, Shanghai Jiao Tong University School of Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Shanghai Shen Kang Hospital Development Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Xinhua Hospital, Shanghai Jiao Tong University School of Medicine</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluates life quality of patients who were diagnosed with gallbladder benign
      disease through Gastrointestinal Quality of Life Index (GIQLI) scale. Researchers will
      establish a database including 20,000 patients. Through observational followup and statistic
      analysis，identifing a model or scale to standardized surgical indication, help surgeons and
      patients determine the best treatment decision.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The incidence of gallbladder benign diseases are increasing today. Most patients are
      accepting cholecystectomy. Is it better postoperation for this sort of patients? In other
      words, there is no specific indication for cholecystectomy in gallbladder benign diseases.
      Investigators want to explore the specific surgical indication for these patients so that
      surgeons could help patients make the best decision according to our evaluation model. This
      model may be a scale that summarizes and quantizes correlative factors of individual, which
      will be discussed by statisticians and experts of biliary surgery.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>December 2016</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">September 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Life Quality (Through GIQLI:Gastrointestinal Quality of Life Index)</measure>
    <time_frame>Every three months, up to 18 months</time_frame>
    <description>Patients with surgery must including preoperative score</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The Rate of Accidentally Gallbladder Carcinoma During Cholecystectomy</measure>
    <time_frame>Through study completion, an average of 18 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The Rate of Abdominal Pain After Cholecystectomy</measure>
    <time_frame>Through study completion, an average of 18 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The Rate of Diarrhea After Cholecystectomy</measure>
    <time_frame>Through study completion, an average of 18 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The Rate of Abdominal Distension After Cholecystectomy</measure>
    <time_frame>Through study completion, an average of 18 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital Stay</measure>
    <time_frame>Through study completion, an average of 18 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total Expense of Patients Including Medication、Operating Costs and Check-Up Expense</measure>
    <time_frame>Through study completion, an average of 18 months</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">20000</enrollment>
  <condition>Gallbladder Stone</condition>
  <condition>Cholecystitis</condition>
  <condition>Gallbladder Polyps</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>No intervention</intervention_name>
    <description>No intervention. Treatment are accordance with clinical practice.</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients Diagnosed with Gallbladder Benign Disease.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients diagnosed with gallbladder benign disease, including gallbladder
             stone、cholecystitis and polypoid lesions of gallbladder from December 2016 to
             September 2018.

          -  Have been clearly informed the purpose of this study, methods and other information,
             voluntarily participate in this study and sign informed consent.

        Exclusion Criteria:

          -  Complicated with bile duct stones and other biliary tract disease or suspected with
             gallbladder carcinoma、biliary tract cancer.

          -  Complicated with severe diseases such as organ dysfunction that cannot accept surgery

          -  Abdominal operation history.

          -  Pregnant or lactation.

          -  Coagulopathy.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Zhaohui Tang, Phd, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Xinhua Hospital,School of Medicine,Shanghai Jiao Tong University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Zhaohui Tang, Phd, MD</last_name>
    <phone>+86 13601789458</phone>
    <email>tangzhaohui@ahoo.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Zhang Yong</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200092</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Yong Zhang, MD,PhD</last_name>
      <phone>+86 21 25078999-7905</phone>
    </contact>
    <investigator>
      <last_name>Yong Zhang, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Houbao Liu, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Tao Suo, MD,PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jian Wang, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Wei Chen, MD,PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Yajin Chen, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Yunyao Xu, MD,PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Xiujun Cai, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Xiao Liang, MD,PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Lin Ji, MD,PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jianying Lou, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ji Wang, MD,PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Yu He, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dajiang Li, MD,PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Minhua Zheng, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Zhaihai Mao, MD,PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Guilong Deng, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Guangwen Zhou, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Zunqiang Zhou, MD,PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Baomin Shi, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Donglei Zhou, MD,PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Feng Shen, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Chenghao Shao, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Gang Jin, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Lunxiu Qin, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <results_reference>
    <citation>da Costa DW, Bouwense SA, Schepers NJ, Besselink MG, van Santvoort HC, van Brunschot S, Bakker OJ, Bollen TL, Dejong CH, van Goor H, Boermeester MA, Bruno MJ, van Eijck CH, Timmer R, Weusten BL, Consten EC, Brink MA, Spanier BWM, Bilgen EJS, Nieuwenhuijs VB, Hofker HS, Rosman C, Voorburg AM, Bosscha K, van Duijvendijk P, Gerritsen JJ, Heisterkamp J, de Hingh IH, Witteman BJ, Kruyt PM, Scheepers JJ, Molenaar IQ, Schaapherder AF, Manusama ER, van der Waaij LA, van Unen J, Dijkgraaf MG, van Ramshorst B, Gooszen HG, Boerma D; Dutch Pancreatitis Study Group. Same-admission versus interval cholecystectomy for mild gallstone pancreatitis (PONCHO): a multicentre randomised controlled trial. Lancet. 2015 Sep 26;386(10000):1261-1268. doi: 10.1016/S0140-6736(15)00274-3.</citation>
    <PMID>26460661</PMID>
  </results_reference>
  <results_reference>
    <citation>Shabanzadeh DM, Sørensen LT, Jørgensen T. A Prediction Rule for Risk Stratification of Incidentally Discovered Gallstones: Results From a Large Cohort Study. Gastroenterology. 2016 Jan;150(1):156-167.e1. doi: 10.1053/j.gastro.2015.09.002. Epub 2015 Sep 14.</citation>
    <PMID>26375367</PMID>
  </results_reference>
  <results_reference>
    <citation>Cotton PB, Durkalski V, Romagnuolo J, Pauls Q, Fogel E, Tarnasky P, Aliperti G, Freeman M, Kozarek R, Jamidar P, Wilcox M, Serrano J, Brawman-Mintzer O, Elta G, Mauldin P, Thornhill A, Hawes R, Wood-Williams A, Orrell K, Drossman D, Robuck P. Effect of endoscopic sphincterotomy for suspected sphincter of Oddi dysfunction on pain-related disability following cholecystectomy: the EPISOD randomized clinical trial. JAMA. 2014 May;311(20):2101-9. doi: 10.1001/jama.2014.5220.</citation>
    <PMID>24867013</PMID>
  </results_reference>
  <verification_date>October 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 25, 2016</study_first_submitted>
  <study_first_submitted_qc>October 28, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 1, 2016</study_first_posted>
  <last_update_submitted>October 28, 2016</last_update_submitted>
  <last_update_submitted_qc>October 28, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 1, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Xinhua Hospital, Shanghai Jiao Tong University School of Medicine</investigator_affiliation>
    <investigator_full_name>Zhaohui Tang</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cholecystitis</mesh_term>
    <mesh_term>Acalculous Cholecystitis</mesh_term>
    <mesh_term>Cholelithiasis</mesh_term>
    <mesh_term>Cholecystolithiasis</mesh_term>
    <mesh_term>Gallstones</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Database including 20000 patients diagnosed with gallbladder benign disease will be available in the website and investigators' article.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

